Healthcare delivery

Lung health

Lung diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma impact more than 471 million people worldwide. Multiple determinants of health, including poverty, smoking, air pollution, and proximity to healthcare, contribute to poor lung outcomes and may act as barriers to detection, diagnosis, and guideline-based care.

We aim to improve lung health outcomes through collaborations that accelerate national level progress with local impact — such as the Lung Ambition Alliance and the International Respiratory Coalition — bringing earlier detection, guideline-directed care and prevention to communities with the greatest needs.

Rare Disease

People living with a rare disease face severe physical, emotional and financial burdens, experiencing significantly poorer quality of life than the general population, and particularly affect children. Diagnostic delays are long, on average five years with 70% misdiagnosed, while treatment options remain limited, which also drives economic strain. We aim to transform the lives of those affected by shortening diagnosis times, improving access to care and effective treatments, and advocating for equitable health policies for rare diseases.

Healthy Heart Africa

Hundreds of millions of people worldwide live with cardiorenal diseases, like hypertension, diabetes and chronic kidney disease. We collaborate to combat the rising burden of these diseases through programmes that reach high-risk populations, strengthen the delivery of primary care and enhance access to medicines and guideline-based care. Our flagship Healthy Heart Africa Programme is active in nine countries and has been making an impact for over a decade.

Cancer Care Africa

Cancer is the second leading cause of death worldwide. The global burden of cancer is expected to grow, with over 30 million newly diagnosed patients estimated by 2040. Two thirds of those patients are expected to be in low- and middle-income countries.

We see a future where cancer is no longer a cause of death and are committed to transforming outcomes for people living with cancer through innovative medicines, powerful collaborations and a purpose-driven team. One example is our Cancer Care Africa programme which focuses on creating a more robust cancer ecosystem through capacity building, screening and earlier diagnosis, patient empowerment and access to medicines.